Diagnosis of immune thrombocytopenic purpura in children

Current Opinion in Hematology

Volumn 14, Issue 5, 2007, Pages 520-525

  Geddis, Amy E ^a,c   Balduini, Carlo L ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biopsy; Bone marrow aspiration; Bruising; Immune thrombocytopenic purpura; Petechiae; Platelet antibodies

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; RHESUS D ANTIBODY; THROMBOCYTE ANTIBODY;

BLOOD CELL COUNT; BLOOD EXAMINATION; BLOOD STAIN; BONE MARROW BIOPSY; CELL SIZE; CLINICAL EVALUATION; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; GIEMSA STAIN; HISTORY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MUCOSAL BLEEDING; PETECHIA; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; THROMBOCYTE; THROMBOCYTOPENIA;

ADRENAL CORTEX HORMONES; AUTOANTIBODIES; BIOPSY, NEEDLE; BLOOD PLATELETS; BONE MARROW; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMORRHAGE; HUMANS; MALE; MUCOUS MEMBRANE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SENSITIVITY AND SPECIFICITY;

EID: 34648833009     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3282ab98f2     Document Type: Review

References (52)

1. Bussel JB, Zacharoulis S, Kramer K, et al. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to nonimmune cases of thrombocytopenia. Pediatr Blood Cancer 2005; 45:176-183.
2. Berkowitz RL, Bussel JB, McFarland JG. Alloimmune thrombocytopenia: state of the art 2006. Am J Obstet Gynecol 2006; 195:907-913.
3. Cines DB, McKenzie SE, Siegel DL. Mechanisms of action of therapeutics in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003; 25 (Suppl 1):S52-S56.
4. Sneller MC, Wang J, Dale JK, et al. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 1997; 89:1341-1348.
5. Schaffer AA, Salzer U, Hammarstrom L, et al. Deconstructing common variable immunodeficiency by genetic analysis. Curr Opin Genet Dev (in press).
6. Knight AK, Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 2006; 5:156-159.
7. Reid MM. Bone marrow examination before steroids in thrombocytopenic purpura or arthritis. Acta Paediatr 1992; 81:1052-1053.
8. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
9. Bader-Meunier B, Proulle V, Trichet C, et al. Misdiagnosis of chronic thrombocytopenia in childhood. J Pediatr Hematol Oncol 2003; 25:548-552. Children with chronic inherited thrombocytopenia are often misdiagnosed with autoimmune thrombocytopenic purpura (AITP). This study looks at the features that characterize the mechanism of thrombocytopenia in seven children who were misdiagnosed with chronic AITP.
10. Noris P, Pecci A, Di BF, et al. Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. Haematologica 2004; 89:1219-1225.
11. Lopez JA, Andrews RK, Afshar-Kharghan V, et al. Bernard-Soulier syndrome. Blood 1998; 91:4397-4418.
12. Sullivan KE, Mullen CA, Blaese RM, et al. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 1994; 125:876-885.
13. Greenhalgh KL, Howell RT, Bottani A, et al. Thrombocytopenia- absent radius syndrome: a clinical genetic study. J Med Genet 2002; 39:876-881.
14. King S, Germeshausen M, Strauss G, et al. Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients. Br J Haematol 2005; 131:636-644.
15. Germeshausen M, Ballmaier M, Welte K. MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease. Hum Mutat 2006; 27:296.
16. Dong F, Li S, Pujol-Moix N, et al. Genotype-phenotype correlation in MYH9-related thrombocytopenia. Br J Haematol 2005; 130:620-627.
17. Seri M, Pecci A, Di BF, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003; 82:203-215.
18. Tischkowitz M, Dokal I. Fanconi anaemia and leukaemia: clinical and molecular aspects. Br J Haematol 2004; 126:176-191.
19. Grossfeld PD, Mattina T, Lai Z, et al. The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet A 2004; 129:51-61.
20. Drachman JG. Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood 2004; 103:390-398. In this review, the congenital thrombocytopenia syndromes are discussed with specific attention focused on diagnostic criteria, clinical presentations, genetic etiology, and current medical management.
21. Geddis AE, Kaushansky K. Inherited thrombocytopenias: toward a molecular understanding of disorders of platelet production. Curr Opin Pediatr 2004; 16:15-22.
22. Balduini CL, Savoia A. Inherited thrombocytopenias: molecular mechanisms. Semin Thromb Hemost 2004; 30:513-523.
23. Geddis AE. Inherited thrombocytopenia: congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Semin Hematol 2006; 43:196-203.
24. Petridou M, Barrett AJ. Physical and laboratory characteristics of heterozygote carriers of the Fanconi aplasia gene. Acta Paediatr Scand 1990; 79:1069-1074.
25. Bowles KM, Bloxham DM, Perry DJ, et al. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura. Br J Haematol 2006; 134:320-322.
26. O'Malley T, Ludlam CA, Fox KA, et al. Measurement of platelet volume using a variety of different anticoagulant and antiplatelet mixtures. Blood Coagul Fibrinolysis 1996; 7:431-436.
27. Rajantie J, Javela K, Joutsi-Korhonen L, et al. Chronic thrombocytopenia of childhood: use of noninvasive methods in clinical evaluation. Eur J Haematol 2004; 72:268-272.
28. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346:995-1008. In most children, ITP resolves within 6 months irrespective of whether they receive therapy. ITP in adults is generally chronic, onset is often insidious, and about twice as many women as men are affected. This review focuses on the diagnosis and management of primary ITP.
29. Takubo T, Yamane T, Hino M, et al. Clinical significance of simultaneous measurement of reticulated platelets and large platelets in idiopathic thrombocytopenic purpura. Haematologia (Budap) 2000; 30:183-192.
30. Salvagno GL, Montagnana M, Degan M, et al. Evaluation of platelet turnover by flow cytometry. Platelets 2006; 17:170-177.
31. Sakakura M, Wada H, Abe Y, et al. Usefulness of measurement of reticulated platelets for diagnosis of idiopathic thrombocytopenic purpura. Clin Appl Thromb Hemost 2005; 11:253-261.
32. Rinder HM, Munz UJ, Ault KA, et al. Reticulated platelets in the evaluation of thrombopoietic disorders. Arch Pathol Lab Med 1993; 117:606-610.
33. Kuwana M, Okazaki Y, Satoh T, et al. Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura. Am J Med 2005; 118:1026-1033.
34. Kurata Y, Hayashi S, Kiyoi T, et al. Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia. Am J Clin Pathol 2001; 115:656-664.
35. Koike Y, Yoneyama A, Shirai J, et al. Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thromb Haemost 1998; 79:1106-1110.
36. Fabris F, Cordiano I, Steffan A, et al. Indirect study of thrombopoiesis (TPO, reticulated platelets, glycocalicin) in patients with hereditary macro-thrombocytopenia. Eur J Haematol 2000; 64:151-156.
37. Abe Y, Wada H, Sakakura M, et al. Usefulness of fully automated measurement of reticulated platelets using whole blood. Clin Appl Thromb Hemost 2005; 11:263-270.
38. Koh KR, Yamane T, Ohta K, et al. Pathophysiological significance of simultaneous measurement of reticulated platelets, large platelets and serum thrombopoietin in nonneoplastic thrombocytopenic disorders. Eur J Haematol 1999; 63:295-301.
39. Ballmaier M, Germeshausen M, Schulze H, et al. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood 2001; 97:139-146.
40. Calpin C, Dick P, Poon A, et al. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? Arch Pediatr Adolesc Med 1998; 152:345-347.
41. Dubansky AS, Boyett JM, Falletta J, et al. Isolated thrombocytopenia in children with acute lymphoblastic leukemia: a rare event in a Pediatric Oncology Group Study. Pediatrics 1989; 84:1068-1071.
42. Jubelirer SJ, Harpold R. The role of the bone marrow examination in the diagnosis of immune thrombocytopenic purpura: case series and literature review. Clin Appl Thromb Hemost 2002; 8:73-76.
43. Halperin DS, Doyle JJ. Is bone marrow examination justified in idiopathic thrombocytopenic purpura? Am J Dis Child 1988; 142:508-511.
44. Jones EC, Boyko WJ. Diagnostic value of bone marrow examination in isolated thrombocytopenia. Am J Clin Pathol 1985; 84:665-667.
45. Houwerzijl EJ, Blom NR, van der Want JJ, et al. Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood 2004; 103:500-506.
46. Vesely S, Buchanan GR, Cohen A, et al. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol 2000; 22:55-61.
47. Vesely SK, Buchanan GR, Adix L, et al. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 2003; 25:130-133.
48. Marks MK, Vadamalayan B, Ekert H, et al. Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey. J Paediatr Child Health 2005; 41:52-55.
49. Klaassen RJ, Doyle JJ, Krahn MD, et al. Initial bone marrow aspiration in childhood idiopathic thrombocytopenia: decision analysis. J Pediatr Hematol Oncol 2001; 23:511-518.
50. Eden OB, Lilleyman JS. Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Arch Dis Child 1992; 67:1056-1058.
51. Lutz P, Villega F, Ducassou S, et al. Management of childhood idiopathic thrombocytopenic purpura: a survey of members of the French Society of Pediatric Hematology and Immunology (SHIP). Arch Pediatr 2007; 14:444-449.
52. Cines DB, Bussel JB, McMillan RB, et al. Congenital and acquired thrombocytopenia. Hematology. Am Soc Hematol Educ Program 2004; 390-406.